Showing posts with label 23andMe. Show all posts
Showing posts with label 23andMe. Show all posts

Monday, October 3, 2022

Neanderthals have their 15 minutes of fame!

Do you have Neanderthal DNA?

 

The early ancestors of most of us who have European ancestors just got their 15 minutes of fame this morning thanks to the Nobel Prize awarded to Svante Pääbo.

 

Press release: The Nobel Prize in Physiology or Medicine 2022

Nobel Assembly logo

Press release

2022-10-03

The Nobel Assembly at Karolinska Institutet has today decided to award the 2022 Nobel Prize in Physiology or Medicine to Svante Pääbo for his discoveries concerning the genomes of extinct hominins and human evolution

Humanity has always been intrigued by its origins. Where do we come from, and how are we related to those who came before us? What makes us, Homo sapiens, different from other hominins?

Through his pioneering research, Svante Pääbo accomplished something seemingly impossible: sequencing the genome of the Neanderthal, an extinct relative of present-day humans. He also made the sensational discovery of a previously unknown hominin, Denisova. Importantly, Pääbo also found that gene transfer had occurred from these now extinct hominins to Homo sapiens following the migration out of Africa around 70,000 years ago. This ancient flow of genes to present-day humans has physiological relevance today, for example affecting how our immune system reacts to infections.

Pääbo’s seminal research gave rise to an entirely new scientific discipline; paleogenomics. By revealing genetic differences that distinguish all living humans from extinct hominins, his discoveries provide the basis for exploring what makes us uniquely human.

Where do we come from?

The question of our origin and what makes us unique has engaged humanity since ancient times. Paleontology and archeology are important for studies of human evolution. Research provided evidence that the anatomically modern human, Homo sapiens, first appeared in Africa approximately 300,000 years ago, while our closest known relatives, Neanderthals, developed outside Africa and populated Europe and Western Asia from around 400,000 years until 30,000 years ago, at which point they went extinct. About 70,000 years ago, groups of Homo sapiens migrated from Africa to the Middle East and, from there they spread to the rest of the world. Homo sapiens and Neanderthals thus coexisted in large parts of Eurasia for tens of thousands of years. But what do we know about our relationship with the extinct Neanderthals? Clues might be derived from genomic information. By the end of the 1990’s, almost the entire human genome had been sequenced. This was a considerable accomplishment, which allowed subsequent studies of the genetic relationship between different human populations. However, studies of the relationship between present-day humans and the extinct Neanderthals would require the sequencing of genomic DNA recovered from archaic specimens.

A seemingly impossible task

Early in his career, Svante Pääbo became fascinated by the possibility of utilizing modern genetic methods to study the DNA of Neanderthals. However, he soon realized the extreme technical challenges, because with time DNA becomes chemically modified and degrades into short fragments. After thousands of years, only trace amounts of DNA are left, and what remains is massively contaminated with DNA from bacteria and contemporary humans (Figure 1). As a postdoctoral student with Allan Wilson, a pioneer in the field of evolutionary biology, Pääbo started to develop methods to study DNA from Neanderthals, an endeavor that lasted several decades.

Ancient DNA

Figure 1. DNA is localized in two different compartments in the cell. Nuclear DNA harbors most of the genetic information, while the much smaller mitochondrial genome is present in thousands of copies. After death, DNA is degraded over time and ultimately only small amounts remain. It also becomes contaminated with DNA from e.g. bacteria and contemporary humans.

In 1990, Pääbo was recruited to University of Munich, where, as a newly appointed Professor, he continued his work on archaic DNA. He decided to analyze DNA from Neanderthal mitochondria – organelles in cells that contain their own DNA. The mitochondrial genome is small and contains only a fraction of the genetic information in the cell, but it is present in thousands of copies, increasing the chance of success. With his refined methods, Pääbo managed to sequence a region of mitochondrial DNA from a 40,000-year-old piece of bone. Thus, for the first time, we had access to a sequence from an extinct relative. Comparisons with contemporary humans and chimpanzees demonstrated that Neanderthals were genetically distinct.

Sequencing the Neanderthal genome

As analyses of the small mitochondrial genome gave only limited information, Pääbo now took on the enormous challenge of sequencing the Neanderthal nuclear genome. At this time, he was offered the chance to establish a Max Planck Institute in Leipzig, Germany. At the new Institute, Pääbo and his team steadily improved the methods to isolate and analyze DNA from archaic bone remains. The research team exploited new technical developments, which made sequencing of DNA highly efficient. Pääbo also engaged several critical collaborators with expertise on population genetics and advanced sequence analyses. His efforts were successful. Pääbo accomplished the seemingly impossible and could publish the first Neanderthal genome sequence in 2010. Comparative analyses demonstrated that the most recent common ancestor of Neanderthals and Homo sapiens lived around 800,000 years ago.

Map

Figure 2. A. Pääbo extracted DNA from bone specimens from extinct hominins. He first obtained a bone fragment from Neandertal in Germany, the site that gave name to the Neanderthals. Later, he used a finger bone from the Denisova Cave in southern Siberia, the site that gave name to Denisovans. B. Phylogenetic tree showing the evolution and relationship between Homo sapiens and the extinct hominins. The phylogenetic tree also illustrates the gene flows discovered by Pääbo.

Pääbo and his co-workers could now investigate the relationship between Neanderthals and modern-day humans from different parts of the world. Comparative analyses showed that DNA sequences from Neanderthals were more similar to sequences from contemporary humans originating from Europe or Asia than to contemporary humans originating from Africa. This means that Neanderthals and Homo sapiens interbred during their millennia of coexistence. In modern day humans with European or Asian descent, approximately 1-4% of the genome originates from the Neanderthals (Figure 2).

A sensational discovery: Denisova

In 2008, a 40,000-year-old fragment from a finger bone was discovered in the Denisova cave in the southern part of Siberia. The bone contained exceptionally well-preserved DNA, which Pääbo’s team sequenced. The results caused a sensation: the DNA sequence was unique when compared to all known sequences from Neanderthals and present-day humans. Pääbo had discovered a previously unknown hominin, which was given the name Denisova. Comparisons with sequences from contemporary humans from different parts of the world showed that gene flow had also occurred between Denisova and Homo sapiens. This relationship was first seen in populations in Melanesia and other parts of South East Asia, where individuals carry up to 6% Denisova DNA.

Pääbo’s discoveries have generated new understanding of our evolutionary history. At the time when Homo sapiens migrated out of Africa, at least two extinct hominin populations inhabited Eurasia. Neanderthals lived in western Eurasia, whereas Denisovans populated the eastern parts of the continent. During the expansion of Homo sapiens outside Africa and their migration east, they not only encountered and interbred with Neanderthals, but also with Denisovans (Figure 3).

Paleogenomics and its relevance

Through his groundbreaking research, Svante Pääbo established an entirely new scientific discipline, paleogenomics. Following the initial discoveries, his group has completed analyses of several additional genome sequences from extinct hominins. Pääbo’s discoveries have established a unique resource, which is utilized extensively by the scientific community to better understand human evolution and migration. New powerful methods for sequence analysis indicate that archaic hominins may also have mixed with Homo sapiens in Africa. However, no genomes from extinct hominins in Africa have yet been sequenced due to accelerated degradation of archaic DNA in tropical climates.

Thanks to Svante Pääbo’s discoveries, we now understand that archaic gene sequences from our extinct relatives influence the physiology of present-day humans. One such example is the Denisovan version of the gene EPAS1, which confers an advantage for survival at high altitude and is common among present-day Tibetans. Other examples are Neanderthal genes that affect our immune response to different types of infections.

Pääbo's discoveries

Figure 3. Pääbo’s discoveries have provided important information on how the world was populated at the time when Homo sapiens migrated out of Africa and spread to the rest of the world. Neanderthals lived in the west and Denisovans in the east on the Eurasian continent. Interbreeding occurred when Homo sapiens spread across the continent, leaving traces that remain in our DNA.

What makes us uniquely human?

Homo sapiens is characterized by its unique capacity to create complex cultures, advanced innovations and figurative art, as well as by the ability to cross open water and spread to all parts of our planet (Figure 4). Neanderthals also lived in groups and had big brains (Figure 4). They also utilized tools, but these developed very little during hundreds of thousands of years. The genetic differences between Homo sapiens and our closest extinct relatives were unknown until they were identified through Pääbo’s seminal work. Intense ongoing research focuses on analyzing the functional implications of these differences with the ultimate goal of explaining what makes us uniquely human.

Denisova, Neanderthal and H. sapiens

Figure 4. Pääbo’s seminal work provides a basis for explaining what makes us uniquely human.

Key publications

Krings M, Stone A, Schmitz RW, Krainitzki H, Stoneking M, Pääbo S. Neandertal DNA sequences and the origin of modern humans. Cell. 1997:90:19-30.

Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M, Patterson N, Li H, Zhai W, Fritz MH, Hansen NF, Durand EY, Malaspinas AS, Jensen JD, Marques-Bonet T, Alkan C, Prüfer K, Meyer M, Burbano HA, Good JM, Schultz R, Aximu-Petri A, Butthof A, Höber B, Höffner B, Siegemund M, Weihmann A, Nusbaum C, Lander ES, Russ C, Novod N, Affourtit J, Egholm M, Verna C, Rudan P, Brajkovic D, Kucan Ž, Gušic I, Doronichev VB, Golovanova LV, Lalueza-Fox C, de la Rasilla M, Fortea J, Rosas A, Schmitz RW, Johnson PLF, Eichler EE, Falush D, Birney E, Mullikin JC, Slatkin M, Nielsen R, Kelso J, Lachmann M, Reich D, Pääbo S. A draft sequence of the Neandertal genome. Science. 2010:328:710-722.

Krause J, Fu Q, Good JM, Viola B, Shunkov MV, Derevianko AP, Pääbo S. The complete mitochondrial DNA genome of an unknown hominin from southern Siberia. Nature. 2010:464:894-897.

Reich D, Green RE, Kircher M, Krause J, Patterson N, Durand EY, Viola B, Briggs AW, Stenzel U, Johnson PL, Maricic T, Good JM, Marques-Bonet T, Alkan C, Fu Q, Mallick S, Li H, Meyer M, Eichler EE, Stoneking M, Richards M, Talamo S, Shunkov MV, Derevianko AP, Hublin JJ, Kelso J, Slatkin M, Pääbo S. Genetic history of an archaic hominin group from Denisova Cave in Siberia. Nature. 2010:468:1053-1060.

Meyer M, Kircher M, Gansauge MT, Li H, Racimo F, Mallick S, Schraiber JG, Jay F, Prüfer K, de Filippo C, Sudmant PH, Alkan C, Fu Q, Do R, Rohland N, Tandon A, Siebauer M, Green RE, Bryc K, Briggs AW, Stenzel U, Dabney J, Shendure J, Kitzman J, Hammer MF, Shunkov MV, Derevianko AP, Patterson N, Andrés AM, Eichler EE, Slatkin M, Reich D, Kelso J, Pääbo S. A high-coverage genome sequence from an archaic Denisovan individual. Science. 2012:338:222-226.

Prüfer K, Racimo F, Patterson N, Jay F, Sankararaman S, Sawyer S, Heinze A, Renaud G, Sudmant PH, de Filippo C, Li H, Mallick S, Dannemann M, Fu Q, Kircher M, Kuhlwilm M, Lachmann M, Meyer M, Ongyerth M, Siebauer M, Theunert C, Tandon A, Moorjani P, Pickrell J, Mullikin JC, Vohr SH, Green RE, Hellmann I, Johnson PL, Blanche H, Cann H, Kitzman JO, Shendure J, Eichler EE, Lein ES, Bakken TE, Golovanova LV, Doronichev VB, Shunkov MV, Derevianko AP, Viola B, Slatkin M, Reich D, Kelso J, Pääbo S. The complete genome sequence of a Neanderthal from the Altai Mountains. Nature. 2014:505: 43-49.

>Svante Pääbo was born 1955 in Stockholm, Sweden. He defended his PhD thesis in 1986 at Uppsala University and was a postdoctoral fellow at University of Zürich, Switzerland and later at University of California, Berkeley, USA. He became Professor at the University of Munich, Germany in 1990. In 1999 he founded the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany where he is still active. He also holds a position as adjunct Professor at Okinawa Institute of Science and Technology, Japan.

Illustrations: © The Nobel Committee for Physiology or Medicine. Illustrator: Mattias Karlén


The Nobel Assembly, consisting of 50 professors at Karolinska Institutet, awards the Nobel Prize in Physiology or Medicine. Its Nobel Committee evaluates the nominations. Since 1901 the Nobel Prize has been awarded to scientists who have made the most important discoveries for the benefit of humankind.

Nobel Prize® is the registered trademark of the Nobel Foundation

Press release: The Nobel Prize in Physiology or Medicine 2022. NobelPrize.org. Nobel Prize Outreach AB 2022. Mon. 3 Oct 2022.  https://www.nobelprize.org/prizes/medicine/2022/press-release/ 

 

Do you have Neanderthal DNA?

23andMe is currently the only major DNA testing company which reports to us information about our Neanderthal DNA inheritance:

"Hey David! You have more Neanderthal DNA than 45% of other customers."

"You inherited a small amount of DNA from your Neanderthal ancestors. Out of the 7,462 variants we tested, we found 236 variants in your DNA that trace back to the Neanderthals."

"All together, your Neanderthal ancestry accounts for less than ~2 percent of your DNA."

"You have one variant associated with being less likely to have a fear of heights.
You have one variant associated with being a better sprinter than distance runner.
You have one variant associated with being more likely to sweat during a workout.
You have one variant associated with being less likely to have a chin dimple." 
 

Read more Neanderthal DNA in Svante's best selling 2014 book:

 

 

 

 


Sunday, August 7, 2022

My Ethnicity Results -- 2022

 

Two years ago I blogged about my ethnicity as predicted by five different DNA Labs: "Should we CELEBRATE genetic Ethnicity?" At the time I had "commissioned" Celebrate DNA to make me a tee shirt documenting these five results:

  

I decided to check each of these predictions today to see what changes, if any, had been made. 

Living DNA

  • Great Britain and Ireland  100 %  (last updated February 3, 2020).

FTDNA

  • Ireland 45%; 
  • England, Scotland and Wales trace.

Ancestry

23andMe

  • British and Irish 62.9%

 My Heritage:

  • English 53.1%
  • Irish, Scottish, and Welsh 5.5%

So, what should I wear to the next family reunion?

 

Saturday, April 4, 2020

SAVE THE DATE: Requires advanced registration



FREE WEBINAR From SCGS, Saturday, May 2, 2020 at 10:00 AM Pacific

 


When Prussian Grandpa Contributed 
No DNA, Can We Find Out Who Did?

Free Webinar from SCGS

Saturday, May 2, 2020,
10:00 AM (Pacific Time)

Register here:
ABOUT THE PRESENTATION
When three siblings did not receive any DNA from their supposed maternal grandfather, a systematic research plan traced the origin of the biological grandfather. Family oral histories, digital phasing, DNA testing of many extended family members and analysis of xDNA inheritance patterns were needed to find the real source of that missing DNA. It was from Donaghadee, Ireland rather than Prussia.

ABOUT THE SPEAKER
David Dowell, PhD, was a librarian for 35 years and a special investigative officer in the USAF for 4 years and has two degrees in history and two in library science. He has researched family histories since the 1960s. His most recent books are NextGen Genealogy: The DNA Connection (2015) and Crash Course in Genealogy (2011). Previously he taught “Genealogy Research” and “Ethics in the Information Age” at Cuesta College and chaired the Genealogy Committee and the Ethics Committee of the American Library Association. He blogs as “Dr. D Digs Up Ancestors” at http://blog.ddowell.com and coordinates three DNA projects.




HANDOUT

A handout will be available shortly before the presentation. A link will be included in a reminder that will be sent the day before the session.

2020 Webinar Times
1st Saturdays                                   3rd Wednesdays
10:00 AM Pacific                             6:00 PM Pacific
11:00 AM Mountain                        7:00 PM Mountain
12:00 PM Central                            8:00 PM Central
1:00 PM Eastern                              9:00 PM Eastern


ABOUT THE SCGS
JAMBOREE EXTENSION SERIES WEBINARS
A goal of the Southern California Genealogical Society is to offer educational opportunities to genealogists and family history enthusiasts everywhere. The Jamboree Extension Webinar Series helps delivers those opportunities.

COST
The initial webcast of each session is offered to the public free of charge. 

Webinars are archived and available only to SCGS members as a benefit of membership in the society. The webinar archive can be found at http://www.scgsgenealogy.com/webinar/archive-index.html.

Thursday, September 13, 2018

New ways to look at your old DNA test results



Two announcements yesterday each give many of us something new to look at with some of our old DNA results. Both AncestryDNA and MyHeritage made important blog posts:


Transfers to MyHeritage:

MyHeritage tweeted that the company can now accept additional raw data transfers. However, note that there may be a real advantage in doing it before December 1st: 
We're excited to announce that we now support the upload of 23andMe v5 and Living DNA data files! Upload your DNA data now to receive DNA Matches and ethnicity estimates on MyHeritage for free. Read more: ht.ly/VP5630lNlya
The 23andMe v5 chip is the one the company has been using since the summer of 2017. This new conversion ability of MyHeritage will allow me to transfer kits of several of my family members who tested at 23andMe in the last two years. Previously, these kits could only be compared with other non-23andMe kits in the separate Genesis database at GEDmatch. 

Note that other newer entries to the DNA testing arena such as Living DNA also use this same chip and can be uploaded to use the diagnostic tools and matching database of MyHeritage that have become increasingly useful in the past year.


"Ancestry Unveils More Detailed and Precise Ethnicity Estimates"

The long anticipated update of the ethnicity estimates, at least for US customers were rolled out yesterday. This will give those of us who have tested at Ancestry something to ponder about. Chief Scientific officer Dr. Catherine Ball blogged:

Today, we announce that Ancestry will deliver ethnicity estimates with increased precision to its customers, through a new algorithm that analyzes longer segments of genetic information, marking an important evolution in the way we interpret DNA data. Having built and expanded our DNA reference panel, we have a better understanding of genetic signatures globally, can break down geographic ethnicity estimates with greater specificity and give you a more detailed picture of your origins.
Whether or not you agree that your new estimates more accurately describe your family's migration, they will give us much to discuss. Below is a summary of changes for my own estimates:

However, this summary does not tell me that some previous ethnicities dropped off completely in this upgrade. For me these were Caucasus 4%, Africa North 2% and Native American 1%. In neither version did Ancestry pick up on my known Finish ancestry which MyHeritage pegged at 2%. Sweden and Norway have not been called out in any of my other tests  They At least this gives me things to ponder.

What do you think about your new results?

Saturday, March 10, 2018

Spit or Swab?



Most of us who have done DNA testing have anecdotal impressions about the success of "spit tests" and "swab tests" for collecting DNA samples. Some of us may still have skepticism about whether a little saliva can provide accurate scientific results. On this later question, I was reassured shortly after we moved to Nashville in 2012. In late 2009 my wife and I had been beta testers for 23andMe when the company was expanding from health related testing to ancestry testing. As a result we both had pre-FDA intervention reports on multiple potential health conditions and drug interactions.

Although I wanted to believe the results, I was born in Missouri -- the Show Me state. Therefore, I had a bit of residual skepticism. Shortly after we arrived in Nashville, we enrolled in Vanderbilt University Medical Center's PREDICT program which aimed at matching drug reaction information with patients' electronic medical records. For this program blood was drawn in a clinical setting and was processed in the Medical Center's labs. On a half dozen comparable tests, both my wife and I got results and interpretations from Vanderbilt that validated those we have previously received based on 23andMe's spit tests. My wife was flagged for statins and I was identified as a faster than average metabolizer of certain blood thinners by both our spit tests and our blood tests. Saliva DNA tests seemed to work just fine.  

However, the question of whether spit tests or swab tests were more likely to get usable results in the lab still remained. My wife sometimes says that her family has a "no spit" gene. It took her three tries to produce a usable sample for Ancestry. It took her sister two tries at Ancestry. Their brother was never successful in producing a readable sample for 23andMe. After two tries the company refunded his money. 

I just retested a grandson a spit test for 23andMe and that result is still pending. The grandson is not biologically related to my wife's family. 

All four of the above family members have passed swab tests on the first try with MyHeritage or FTDNA. Most of you know that samples sent to these two companies are processed through the same lab in Houston.


The Poll:

How unusual is my wife's family? Maybe I should rephrase that. How unusual is their DNA testing success? To cast a wider net to collect some data I posted a poll this week on the "Genetic Genealogy Tips and Techniques" Facebook page which claims more than 36,000 members. For a variety of reasons this turned out to be a "quick and dirty" data collection survey. I was not clever enough to bend Facebook's poll instrument to allow responders to easily enter multiple results when multiple family members had been tested. All the data is self reported from customers. I tried to enter data customers provided in comments. My quick and unscientific poll ended up with 1.333 usable testing experiences.

 

While testing companies will claim a higher success rate than is shown in my results, I would welcome their data to prove it. Intuitively, these data seem to reflect what many of us experience. This is not intended to be the definitive final word on this question. What do you think?

I'd love to have more data. 


 

Saturday, March 25, 2017

Ethnic Origins Predictions Affected by Random Autosomal Inheritance



Predictions of our ethnic origins are one of the biggest draws to get people to order a DNA testing kit. Almost all of these predictions are based on our autosomal DNA. That's the only DNA tested by Ancestry, 23andMe and MyHeritage. Family Tree DNA offers these predictions as part of its Family Finder test results. Marketing surveys suggest that more more than half of millennials who take genealogy DNA tests are doing it only or primarily to find out whether they should be wearing kilts or lederhosen to the next family gathering. 

In spite of the warnings of prominent genetic genealogists that these projections at present are one of the softest parts of the science of genetic genealogy, the advertising seen on television and elsewhere continues to emphasize predictions of ethnic origins. 

The Legal Genealogist, Judy G. Russell, is one of the most outspoken critics of the credibility of the predictions we are given. In an August 14, 2016 blog post "Those Percentages, if you must", she reiterated:
The Legal Genealogist says that the ethnicity estimates part of autosomal DNA tests are not a whole lot more than cocktail party conversation,
It just doesn’t seem to matter.
Really.
You can’t rely on DNA tests to give you exact percentages of your ethnic origins beyond the continental level (European, versus African, versus Asian).
 
Judy's conclusion is a valid one. Part of the problem is that this part of our science is still immature: 

  1. The population geneticists really can't tell us where all of our ancestors were living 500 years ago;
  2. Very few of us have pedigree charts that inform us about who all of our genealogical ancestors were in 1500 and where they resided; 
  3. Although atDNA tests generally sample 500,000 to 700,000 locations to make these ethnic predictions, this is a small percentage of our entire genomes; AND   
  4. Inheritance of our atDNA is random.
We all know that we inherited 50% of our atDNA from our fathers and 50% from our mothers. But how many of us know how much of our atDNA we inherited from our maternal grandfather? Would this make a difference in our predicted ethnicity? Of course it would.

Last month I published results from atDNA tests taken by two of my grandsons at MyHeritage. They are full siblings. Their other grandfather is primarily Ashkenazi. His Family Finder origins prediction is shown below. 




None of the other three grandparents show the presence of any Ashkenazi genetic component in their Family Finder results. My daughter-in-law was reported in her Family Finder results to be 42% Ashkenazi. [23andMe reported 48%.] Although I am not comparing apples to oranges in this post, I may be comparing different varieties of apples to each other by comparing testing results from three different companies. However, different family members have tested at different companies. These cross testing companies comparisons should not effect my main point in this post. If you have data that would dispute that, please share and we all will learn something.

My main point is that my grandson who appeared to inherit only 22% of his atDNA from his Ashkenazi grandfather in my previous post, was shown by Family Finder to have significantly less Ashkenazi ethnicity than did his full sibling who appears to have inherited 26% of his atDNA from that grandfather. 

This is an extremely small sample and the results may be distorted because results from different companies are being compared. However, I encourage you to try this at home if you have test results reflecting the difference between the atDNA inheritance patterns of sibling grandchildren. The result I report above is in accordance with what common sense would lead me to believe. If you have results that would support or refute this tentative hypothesis, I would love to see it. Maybe we all will learn something.


Wednesday, December 16, 2015

Promethease: For Your Health & Insomnia



On Sunday The Legal Genealogist, also known as Judy Russell, posted "All you want for Christmas..." is a DNA test kit. Her post began:
So… if that’s you this year, if what you really want for Christmas is a DNA test kit … which one do you get?
Her answer was very thorough and I will not try to duplicate it here. However, you would do well to read her thoughts. Her analysis of the options is sound, genealogically speaking, and she left very little to be added. Except....


Testing only for health related information:

All of us should know by now DNA testing is definitely not a case where "one size fits all." Judy knew this and she provided many viable options, but she left one out and I believe she did that on purpose. We will get back to what her purpose may have been later in this post.

In the last several days I have been approached three times by individuals asking what DNA test I would recommend for gaining health related information. Two wish to self test and the other is looking for holiday gift ideas for two sons. All of the would-be test takers are middle-aged. If they test they would become the kind of test takers all serious genetic genealogists love to hate. They all know little and claim no interest in knowing more about their ancestry except for how their genes may impact their own health. In addition they all claim not to be concerned about their carrier status for diseases that the FDA now permits 23andMe to report to clients. That really doesn't leave much from which to choose. 

Some information about prescription drug interactions with an individual's genome can purchased through a test offered by Healthspek which I have discussed in previous posts. However, that is only one part of the health related information inquiring minds would like to know about what is recorded within their personal genomes.

Several years ago I took a quick look at Promethease but found it to be not as user friendly as similar information presented by 23andMe. Since the reports generated by both companies were coming from the same source data, I opted to concentrate on those on my site at 23andMe


Hemochromatosis Carriers:

During the holiday season three years ago we offered to gift our children and their significant others with 23andMe test kits. One of the things we learned from this was that both one son and his wife were carriers for hemochromatosis -- which causes one's body to accumulate too much iron. The parents were not flagged as being at risk for developing this disorder but their offspring -- our young grandchildren -- were at elevated risk. I discussed this finding with my daughter-in-law who is a gynecological surgeon and medical school faculty member. I recommended that she relay this information to the boys' pediatrician so that he could make note of it in their files and monitor this possibility. My MD daughter-in-law asked if I would write a long email to the pediatrician that explained this development to him.

I did so but I found this to be ironic (pun intended) since I'm an information doctor not a medical professional. Some of you know that I have never had a biological science course of any description in my life. My insatiable curiosity about DNA was God's punishment of me when She read my transcript and realized my academic deficiency. So much for needing medical professionals to protect and guide us uninitiated civilians as we are introduced to the information in our own genomes. But I digress.


Promethease:

Back in September The Legal Genealogist wrote "A Healthy Choice" as a post to her popular blog. In it she presented a very thorough introduction to Promethease as a source for health related information from our genes.



Rather than trying to repeat her succinct prose my intent is to expand on the personal experiment she reported. Until recently I was unaware that self downloaded raw atDNA results from any of the big three testing companies can be uploaded and processed through Promethease. However, the 23andMe test chip has significantly more health related SNPs than the chips of the other two companies. FTDNA has made conscious decision to stay away to the extent possible from SNPs thought to be health related. This decision was made years ago in order to minimize the potential for regulatory problems with the FDA. As we learn more about our genomes, it is increasingly difficult to avoid SNPs with known health consequences. Ancestry discloses little about its rationale for selecting the SNPs on its chip.


Raw data from each of the major U.S. testing companies when processed through Promethease for three different users: 

23andMe Ancestry Family Finder
Legal Genealogist
Gray 17,613 11,225 10,070
Green 5,281 1,538 1,261
Red 413 255 166
Total 23,307 13,018 11,497
Dr. D
Gray 19,049 11,609 10,348
Green 5,580 1,572 1,296
Red 388 248 153
Total 25,017 13,429 11,797
Dr. D's wife
Gray 18,414 11,245 10,384
Green 5,519 1,491 1,265
Red 429 276 177
Total 24,362 13,012 11,826

Clearly customers get reports on about twice as many SNPs from 23andMe raw data than from the data from competitors. My little study has replicated Judy's. So if your only objective in taking an autosomal DNA test is to learn more about how your genetic component may contribute your future health, 23andMe raw data will give you more to analyze and analyze and analyze. That is what you will be doing if you go this route. Processing raw data from 23andMe or Ancestry only costs $5. Family Finder data costs $7 because xDNA must be downloaded separately and added to the mix to get the most complete picture that can be extracted from those data. If you have raw data from all three companies as does The Legal Genealogist and Dr. D., all your data can be loaded into Promethease at one time and processed for a total of $11.


Alzheimer's risk:

It is easy to drown in the data. In my own report Alzheimer's was associated with 156 SNPs: 56 good; 11 bad and 89 with small associations that have yet to be classified as either good or bad. You cannot look at the predictive power of a single SNP and be confident that you know something about how your genome may affect your future health. The human genome is far to complex for this kind of intellectual short cut.


SNPs currently thought to be related to Dr. D's Alzheimer's risk
If you have that obsessive-compulsive gene and love to pour over all the known data, this may be the test for you. If you have already done an atDNA test, for an additional investment of only $5 or $11 dollars, you can entertain yourself all night!


Holiday sale:

As most of you know 23andMe recently raised the price of its test kit to $199 for U.S. customers. If you are already a 23andMe customer, you recently should have received an offer to order kits for $149. This price is good for purchases completed through 11:59 pm PST on January 8, 2016. What you may not have noticed in the fine print is that you can place up to three separate orders. Each order can be for up to ten kits. This allows one to order as many as thirty kits at this sale price.


Caveat:  

If you are at all interested in using DNA testing to learn ancestry information for genealogical purposes, read Judy's December 6th blog post "Now... and not now" before you order any kit from 23andMe.


Friday, December 4, 2015

Affordable Precision Medicine: The 23andMe Interlude


23andMe DNA Kit

In the first year of the Obama administration much attention was focused on affordable health care. Late that year 23andMe came to my attention when it sought out beta testers for its genealogy application the company was adding to its existing DNA tests for consumer health information. My wife and I quickly signed up and got what, in retrospect, became one of the greatest consumer bargains of all time. My primary motivation for testing was for family history information, but I soon became an advocate for enabling better health care by allowing citizens to "buy" reliable genetic information that might help them understand their current and future health prospects.

For the next 4 years consumers were able to acquire for a very reasonable price, information about:
  • their "differences in sensitivity or in the likelihood or severity of side effects" when taking 25 categories of drugs
  • their health risks -- either elevated, reduced or typical for 122 common disorders; 
  • the presence or absence of 53 "specific genetic variants that can cause certain health conditions" in the person tested; and 
  • the presence or absence of 53 "specific genetic variants that can cause certain health conditions" being "carried" down to offspring.

We generally didn't articulate these reports from 23andMe as having these 4 components. We thought of them as constituting the health report as opposed to the ancestry report that gave us information about our ethnic origins and offered us a chance to connect with unknown relatives who might help us fill in gaps in our family histories. It was only after the FDA took these reports from the marketplace in November 2013 and eventually allowed one of them to come back in 2015 that we began to realize how much we had lost. Note: 23andMe has recently marketed the original full health reports in other English speaking countries who are not protected by the US FDA.

The FDA never presented concrete evidence of actual harm done to consumers by the 23andMe health reports. The agency never alleged that the lab work was substandard or that the company did not really test what it claimed to test. All that the FDA took exception to was the interpretation of the results without the direct involvement of a health professional. The agency alleged that the average citizen might not be able to understand 23andMe's interpretation of the results. 23andMe was mandated to validate that its explanations could be understood on a case by case basis. 

I wish the FDA would apply the same standards to the drug adds  that inundate us every evening during the national news. We are one of 2 countries that allow this kind of promoting prescription drugs directly to public. The other country is New Zealand. These advertising costs contribute to the inflated cost of these drugs when they are prescribed. But I digress.

Within the last few weeks I have been asked to recommend DNA tests that could give information about the current and future health prospects for mature adults who were beyond child bearing age. Healthspek, a local startup about which I blogged a few weeks ago, offers testing for possible drug sensitivity or in the likelihood of or severity of side effects. However, this test costs as much or more than 23andMe. 

Randy Farr, CEO of Healthspek emailed me last week his comparison of the two:


23andMe
Healthspek
Price
23andMe raised their price in October to $199  (from $99).  It is likely they are still operating at a loss even with this increase.
Our website, un-channeled, states $499.  We have sold only one test so far at that price.  The website is not generally reached directly.  Our marketing efforts (through partners and direct) provide a link with this url: http://pgt.healthspek.com/discount.
Try it.  Then use the discount code CYBERMONDAY.  You’ll see a price of $299.  We have the ability to generate codes with varying discounts and private labeling.  This gives us the ability to build in (or not) a commission for channel partners.  $499 is a high enough ceiling that there is always a meaningful discount.
A similar company (www.getcolor.com) offers a genetic test specific to only breast cancer risk for $249.  Other examples exist.
Reporting
23andMe does not do PGT (pharmacogenetic testing). The biggest reason is probably this:  The value in PGT is NOT the underlying raw data,  it is in the translation of that data to decipherable and meaningful results in prescribing drugs).
Part of the cost of our test goes to the production of a patient-specific report that has several components (drug-by-drug metabolizing, gene-by-gene variants, general overview, etc.).
In 1st quarter next year this report will be expanded to include traditional (molecular) drug-drug interactions (this is not genetically driven).  While this is not genetic it is equally important in the task at hand-prescribing drugs more precisely.
So, our focus of our test – prescribing- goes beyond just raw data and even beyond genetics.
This is powerful stuff.
What’s included
Ancestry, carrier markers, some food and wellness.  It also has a social (blood relations) aspect that is cool.
1)      Complete report – drug-by-drug, gene-by-gene.
2)      Telephonic session with certified genetic counselor.
3)      Results deposited in free Lifetime wallet –Healthspek, best PHR on the market (per Apple and Appy Awards).
4)      Simultaneous delivery of results to consumer’s doctor.
General vs. Specialty
23andMe is a good generalist.  But it doesn’t, and can’t, give much help in specific areas that rely on robust research (‘what does this part of the genome mean?’).
Genetic Testing is currently available by many companies in the area of oncology, markers, carrier markers, pharmaco, specific diseases, diet, exercise, etc.
Companies that do specific genetic testing and results will always have a place in this market.  This is because knowledge and its display is what matters, not just the raw data.  23andMe can’t possibly be all things to all people.


This is still just one of the 4 areas previously covered by 23andMe reports. The FDA has cleared 23andMe to resume providing most of its "carrier status" reports. These tell one whether you are likely to transmit to your offspring conditions that are not manifested in you or your spouse. So between 23andMe and Healthspek, two of 23andMe original areas of health information are covered. That still doesn't provide feedback on genetic impact that may affect the health of an adult except for drug interactions--information provided by 23andMe prior to November, 2013.

The only way I know of for you to learn that kind of information is to take a 23andMe, Ancestry or Family Finder (FTDNA) test and subsequently process your raw data at a third part site. Remember, the FDA did not challenge the accuracy of the raw data generated and reported by 23andMe. 23andMe continues to provide this to customers. Online sites like Promethease offer data analysis reports of your raw DNA:
Promethease is a literature retrieval system that builds a personal DNA report based on connecting a file of DNA genotypes to the scientific findings cited in SNPedia
Biomedical researchers, healthcare practitioners and customers of DNA testing services (such as 23andMe, Ancestry.com, FamilyTreeDNA, etc.) use Promethease to retrieve information published about their DNA variations. Most reports cost $5 and are produced in under 10 minutes.

Breaking News

23andMe announced yesterday a temporary price reduction to $149. One quipster commented that he didn't know if this was a $50 price increase from 23andMe's recent price of $99 or a $50 reduction from the current $199 price. In any case if you are interested in buying a 23andMe kit in the US now is the time to act.

It is hard to predict how the current series of changes will affect the utility of the 23andMe product for serious genetic genealogists. Hopefully that will become clearer in coming weeks.

The more things change the more they stay the same. In late 2009 my wife and I bought 23andMe kits as beta testers for their new genealogy matching service for $149. That was half the regular price at the time. As most of you readers know the price has fluctuated over the last 6 years.

As much as many consumers want even cheaper prices, that may not be realistic if we want companies to be able to stay in business. Antonio Regalado reported in October in the Biomedicine News section of the MIT Technology Review:

we’ve seen several announcements by companies trying to lure consumers to learn about their genomes. Something they all have in common: they’re losing money doing it, at least for now.


As we approach the last year of the Obama administration, are we closer to affordable health care and precision medicine? I hope so.